EUVIMEDEUVIMED entdecken
Systematische Übersicht

91 Enhanced Recovery After Surgery (ERAS) in Shoulder Arthroplasty: A Systematic Review of Perioperative Outcomes

H Shinwari, Z Mouyer, A Butt, H Shinwari, A Kamath, S Gill, K Sugand

British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)

DOI: 10.1093/bjs/znag063.162 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von H Shinwari und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enhanced Recovery After Surgery (ERAS) protocols improve outcomes in hip and knee arthroplasty, but their role in shoulder arthroplasty is less defined. This review evaluates ERAS strategies including multimodal, opioid-sparing analgesia on pain, opioid use, length of stay (LOS), and complications.

Method

A systematic search was conducted across multiple databases. Interventions included opioid-free pathways, single-shot (SS-ISB) versus continuous interscalene blocks (C-ISB), liposomal bupivacaine (LB), and adjuncts such as dexamethasone, tranexamic acid (TXA), and periarticular injections (PAI). Analysis followed PRISMA and SWiM guidelines. Pain was measured using the Numerical Rating Scale (NRS; 0 = no pain, 10 = worst pain).

Results

A total of 29 studies with 141,042 patients were included. Pain was reported in 22 studies. Opioid-free pathways achieved median NRS 0 immediately and 4 at 32 hours; only 6% required opioids within 2 weeks. C-ISB reduced early pain versus SS-ISB in the first 12–24 hours, though differences were not significant beyond day 1. LB with or without dexamethasone reduced pain by 2–3 NRS points over 72 hours, similar to C-ISB. Opioid consumption was lower with opioid-free pathways, LB (POD0–3, p < 0.001), and multimodal analgesia; cumulative use was similar between C-ISB and LB. LOS decreased by 0.5–0.7 days with multimodal or LB-based regimens. Complications were low; dexamethasone, TXA, and PAI did not increase risk. C-ISB had isolated issues: 10% catheter dislodgement and two transient sensory disturbances.

Conclusion

Multimodal, opioid-sparing ERAS strategies safely reduce pain, opioid use, and LOS, supporting their adoption as standard care in shoulder arthroplasty.

Zitieren

APA

Shinwari, H., Mouyer, Z., Butt, A., Shinwari, H., Kamath, A., Gill, S., & Sugand, K. (2026). 91 Enhanced Recovery After Surgery (ERAS) in Shoulder Arthroplasty: A Systematic Review of Perioperative Outcomes. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.162

Vancouver

Shinwari H, Mouyer Z, Butt A, Shinwari H, Kamath A, Gill S, et al. 91 Enhanced Recovery After Surgery (ERAS) in Shoulder Arthroplasty: A Systematic Review of Perioperative Outcomes. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.162

BibTeX
@article{Shinwari2026,
  author = {Shinwari, H and Mouyer, Z and Butt, A and Shinwari, H and Kamath, A and Gill, S and Sugand, K},
  title = {91 Enhanced Recovery After Surgery (ERAS) in Shoulder Arthroplasty: A Systematic Review of Perioperative Outcomes},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_6},
  doi = {10.1093/bjs/znag063.162}
}
Kostenlos starten →